HSBC estimates that $512 million in worldwide stimulus funding will go toward green projects. In 2009, 22% of this funding is expected to be spent. South Korea has committed the largest share of its economic stimulus plan, 79%, to green projects, with major programs for job creation and clean technology. The EU has pledged a […]
A new report from the European Commission’s Joint Research Center estimates that the number of genetically modified (GM) crops will reach 124 by 2015, compared to 33 in 2008, and will include GM rice and potato, which are not currently commercialized. GM cotton will account for the largest number of GM crops in 2015, with […]
Drs. Darren E. Zinner and Eric G. Campbell of Brandeis University analyzed the results of a survey of 1,663 life science faculty at 50 US universities with medical schools conducted between September 2006 and February 2007 to examine life science research at US academic medical centers. The mean research time for respondents was 23 hours […]
Biotechnology: Although financing for biotech companies is improving, it still remains tough. In the first half of 2009, funds raised by biotechnology and specialty pharmaceutical firms increased 41% to $8.3 million, excluding revenue from partnerships. Compared to the first half of 2007, financing was down 55%. Money raised through public offerings and alternative financing rose […]
Primary energy consumption rose 1.4% in 2008 for the slowest growth since 2001, according to the BP Statistical Review of World Energy. Non-OECD nations were responsible for most of the demand, as Asia-Pacific represented 87% of this growth, with China’s energy consumption up 7.2%. Globally, oil production increased 0.4% to 380,000 barrels per day (b/d), […]
The total number of pharmaceutical licensing agreements completed between June 2008 and July 2009 declined 17% year over year to 661, according to EvaluatePharma. Oncology remained the top therapeutic area for licensing agreements, with 132 deals, down 18% from the previous year. Compared to previous periods, more oncology deals focused on earlier stages. The number […]
Novartis AG has become the first company to develop a genetic test for a drug’s potential side effects. The test is part of a plan by the company to resubmit Prexige pain drug for FDA approval. Due to the high rate of liver damage associated with Prexige’s use, in 2007 the FDA rejected the drug’s […]
PricewaterhouseCoopers reports that revenues for the 40 largest mining companies (with market capitalization of $2.3 billion or more) increased 23% in 2008 to $349 billion. However, operating expenses grew 27% to $208 billion and net profit declined 14% to $57 billion. Capital expenditures increased 38% to $66 billion. The sharp decline in metal prices in […]
Tests for the rapid diagnosis of swine flu have a high failure rate, according to a study in The Journal of Clinical Virology and a soon-to-be-released study from the Centers for Diseases Control and Prevention. The manufacturers of these tests include Quidel, Inverness Medical Innovations, 3M, Thermo Fisher Scientific, Meridian Bioscience, and Becton, Dickinson. The […]
According to a survey and analysis by the Organization for Economic Co-operation and Development (OECD), investment in innovation and long-term growth is a priority of OECD nations’ economic stimulus packages. Such investments can be grouped into five themes: infrastructure improvements; R&D, science and innovation support; education and human-capital investments; investment and promotion of green technologies; […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
